177 related articles for article (PubMed ID: 3036725)
1. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
Fatome M; Courteille F; Laval JD; Roman V
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
[TBL] [Abstract][Full Text] [Related]
2. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
Mendiondo OA; Connor AM; Grigsby P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
[TBL] [Abstract][Full Text] [Related]
3. [Acute toxicity and radioprotective effectiveness of gammaphos on intramuscular administration to mice].
Kuna P
Radiobiologiia; 1985; 25(1):59-62. PubMed ID: 2983365
[TBL] [Abstract][Full Text] [Related]
4. Some recent data on chemical protection against ionizing radiation.
Fatome M; Laval JD; Roman V
Adv Space Res; 1992; 12(2-3):213-21. PubMed ID: 11537011
[TBL] [Abstract][Full Text] [Related]
5. WR-2721 inhibition of radiation-induced prostaglandin excretion in rats.
Donlon M; Steel L; Helgeson EA; Wolfe WW; Catravas GN
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Feb; 47(2):205-12. PubMed ID: 2984129
[TBL] [Abstract][Full Text] [Related]
6. [Effect of pharmacological agents on the radioprotective activity, toxicity and distribution of 35S-labeled aminopropylaminoethyl-thiophosphate administered perorally].
Grechka II; Belavina LP; Kalistratov GV; Zherebchenko PG
Radiobiologiia; 1979; 19(3):372-6. PubMed ID: 223190
[No Abstract] [Full Text] [Related]
7. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine.
Kuna P; Petýrek P; Jensovský V; Melek J
Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232
[No Abstract] [Full Text] [Related]
8. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
Grigsby P; Maruyama Y
Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
[TBL] [Abstract][Full Text] [Related]
9. Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.
Landauer MR; Castro CA; Benson KA; Hogan JB; Weiss JF
J Appl Toxicol; 2001; 21(1):25-31. PubMed ID: 11180277
[TBL] [Abstract][Full Text] [Related]
10. [Experience in the search of new prolonged-action radiation-protective agents].
Grachev SA; Sverdlov AG; Kropachev EN; Nikanorova NG; Bondarev GN; Drobchenko SN
Radiats Biol Radioecol; 1996; 36(2):190-4. PubMed ID: 8673217
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells.
Purdie JW
Radiat Res; 1979 Feb; 77(2):303-11. PubMed ID: 220662
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913.
Dillon J; Kennedy JC; Pottier RH; Roberts JE
Photochem Photobiol; 1988 Aug; 48(2):235-8. PubMed ID: 2851844
[No Abstract] [Full Text] [Related]
13. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
[TBL] [Abstract][Full Text] [Related]
14. Radioprotective effect of WR-2721 on haematopoiesis in mice. I. Quantitative changes in haematopoiesis.
Brezáni P; Macková N
Radiobiol Radiother (Berl); 1988; 29(5):587-93. PubMed ID: 2852382
[No Abstract] [Full Text] [Related]
15. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
[No Abstract] [Full Text] [Related]
16. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721.
Weiss JF; Hoover RL; Kumar KS
Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528
[TBL] [Abstract][Full Text] [Related]
17. Radioprotective effect of WR-2721 on haematopoiesis in mice. III. Changes in peripheral blood.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):603-8. PubMed ID: 2852384
[No Abstract] [Full Text] [Related]
18. Systemic factors affecting the radioprotective effectiveness of phosphorothioates.
Yuhas JM
Experientia Suppl; 1977; 27():63-70. PubMed ID: 192569
[No Abstract] [Full Text] [Related]
19. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
Rasey JS; Magee S; Nelson N; Chin L; Krohn KA
Radiother Oncol; 1990 Feb; 17(2):167-73. PubMed ID: 2157242
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
